COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 56 filers reported holding COMPASS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,862,162 | -38.1% | 5,513,788 | 0.0% | 0.29% | -30.2% |
| Q2 2023 | $17,533,846 | -2.8% | 5,513,788 | 0.0% | 0.42% | -3.0% |
| Q1 2023 | $18,030,087 | -32.8% | 5,513,788 | +3.4% | 0.43% | -33.3% |
| Q4 2022 | $26,825,936 | +120.6% | 5,333,188 | 0.0% | 0.64% | +105.4% |
| Q3 2022 | $12,160,000 | -13.9% | 5,333,188 | +0.1% | 0.31% | -23.6% |
| Q2 2022 | $14,119,000 | +93.4% | 5,328,088 | 0.0% | 0.41% | +123.4% |
| Q1 2022 | $7,299,000 | -56.8% | 5,328,088 | 0.0% | 0.18% | -52.8% |
| Q4 2021 | $16,890,000 | – | 5,328,088 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 4,400,000 | $22,132,000 | 17.19% |
| Monashee Investment Management LLC | 2,230,441 | $11,219,000 | 4.83% |
| CHI Advisors LLC | 2,829,712 | $14,233,452 | 3.79% |
| CAXTON CORP | 211,159 | $1,062,132 | 2.71% |
| Orbimed Advisors | 22,362,850 | $112,485,136 | 2.15% |
| Vivo Capital, LLC | 3,557,630 | $17,895 | 2.06% |
| DAFNA Capital Management LLC | 602,051 | $3,028,316 | 0.85% |
| Rock Springs Capital Management LP | 5,333,188 | $26,825,936 | 0.64% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 268,307 | $1,349,584 | 0.39% |
| BRAIDWELL LP | 1,814,266 | $9,125,758 | 0.31% |